Completes, Pretest Phase 2

Half Incentive + Blinded

Subject Line: $15.00 Honorarium - 30 Minute Endocrinology Study

Email Content:

Dear Dr. <%LAST%>,

Based on your e-Rewards(R) Medical profile, you are invited to participate in this market research study.

Topic: Endocrinology Study

Cash Honorarium: $15.00

Length of Survey: 30 Minutes

Click Here to Begin the Survey

http://www.e-rewardsmedical.com/survey.do?FT=<%uniqueid%>

If you are unable to reach the survey by clicking on the link above, please contact Member Services and reference your Invitation Code and PIN.

Invitation Code: <%INVITATION_CODE%>

PIN: <%PIN%>

We encourage you to respond quickly. This survey will be available until a predetermined number of responses have been received.

Your honorarium will be sent only once, 2-3 weeks after successfully qualifying and completing the survey. Please save this invitation until payment.

Continue to check your inbox for future opportunities from e-Rewards Medical.

Sincerely,

Linda Roberts

Manager, Member Services

e-Rewards Medical Market Research

5800 Tennyson Parkway

Suite 600

Plano, TX 75024

[email protected]

(214) 365-7699

======================================================

If you have an inquiry or experience problems with this message, please contact Linda Roberts at [email protected].

Please do not reply to this email.

======================================================

Update your profile, view your honorarium status, or cancel your membership online at:

http://www.e-rewardsmedical.com/myaccount.do

Unsubscribe from future emails from e-Rewards:

http://www.e-rewardsmedical.com/EmailOptOut.do?FT=<%uniqueid%>

======================================================

Read our Privacy Policy: http://www.e-rewardsmedical.com/privacypolicy.do

Read our Member Agreement: http://www.e-rewardsmedical.com/memberagreement.do

(C) <%Year%> Research Now Group, Inc. All rights reserved. e-Rewards and the e-Rewards Medical Market Research Design are registered trademarks of Research Now Group, Inc.